Table 1.
Patient | Age (years)/sex | Macrophage grade | Foam cell grade | C pneumoniae PCR | MMP-9 RT-PCR | Stage of atherosclerosis* | Immunostaining | |
C pneumoniae | MMP-9 | |||||||
1 | 58/M | 4+ | 1+ | – | + | VIa | 3+ | 2+ |
2 | 67/M | 1+ | 0 | + | + | VIc | 1+ | 1+ |
3 | 63/M | 2+ | 2+ | – | + | IV | 4+ | 2+ |
4 | 59/M | 2+ | 0 | – | + | Vc | 1+ | 1+ |
5 | 51/M | 3+ | 1+ | – | + | Vc | 2+ | 2+ |
6 | 53/M | 3+ | 2+ | – | + | Vb | 0 | 3+ |
7 | 70/F | 4+ | 3+ | – | + | Va | 3+ | 3+ |
8 | 37/M | 1+ | 0 | – | + | II | 4+ | 4+ |
9 | 66/M | 2+ | 1+ | – | + | Vb | 3+ | 2+ |
10 | 49/M | 2+ | 3+ | – | + | Vb | 0 | 2+ |
11 | 60/M | 2+ | 3+ | – | + | Vb | 1+ | 1+ |
12 | 69/M | 2+ | 3+ | – | – | Vb | 0 | 0 |
13 | 52/M | 4+ | 3+ | – | + | Vc | 0 | 1+ |
14 | 58/M | 3+ | NT | – | + | IV | 2+ | 3+ |
15 | 35/M | 1+ | NT | – | + | I | 0 | 2+ |
16 | 27/M | 2+ | 2+ | + | + | Va | 2+ | 2+ |
17 | 48/M | 1+ | 0 | – | – | Vb | 0 | 0 |
18 | 56/F | 4+ | 4+ | – | NT | VIa | 0 | 2+ |
19 | 55/M | 3+ | 1+ | – | + | Va | 3+ | 1+ |
20 | 53/M | 2+ | 2+ | – | NT | IV | 3+ | 2+ |
21 | 75/M | 1+ | 1+ | – | NT | Vc | 2+ | 2+ |
22 | 68/M | 3+ | 2+ | – | + | Va | 2+ | 3+ |
23 | 71/M | 2+ | 0 | + | + | Va | 1+ | 2+ |
24 | 65/M | 2+ | 1+ | – | – | III | 3+ | 1+ |
25 | 70/M | 2+ | 0 | – | + | Vb | 2+ | 1+ |
26 | 72/M | 3+ | 2+ | – | + | Vc | 2+ | 2+ |
27 | 50/M | 3+ | 3+ | – | + | Vb | 4+ | 2+ |
28 | 59/F | 1+ | 0 | – | – | Va | 0 | 0 |
29 | 69/M | 2+ | 1+ | + | + | Va | 2+ | 1+ |
30 | 76/M | 3+ | 1+ | – | + | Vc | 2+ | 1+ |
31 | 64/M | 2+ | 3+ | – | – | Vc | 0 | 0 |
Immunohistochemistry data shown as grades 0 to 4+.
*Classified according to the recommendations by Stary et al.25
C pneumoniae, Chlamydia pneumoniae; F, female; M, male; MMP-9, matrix metalloproteinase-9; NT, not tested; PCR, polymerase chain reaction; RT-PCR, reverse transcription polymerase chain reaction.